Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 13.50
Ask: 14.50
Change: -0.25 (-1.75%)
Spread: 1.00 (7.407%)
Open: 14.25
High: 14.00
Low: 13.75
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: US Stocks Seen Up Ahead Of Amazon, GM, AT&T

Thu, 23rd Jul 2015 11:23

LONDON (Alliance News) - UK shares are slightly higher Thursday midday, as UK publisher Pearson confirmed it is in talks to sell the FT Group, while Wall Street is called for a positive open ahead of another big day for US earnings reports.

Pearson confirmed it is in advanced discussions over the potential sale of the FT Group, consisting of the Financial Times, a 50% shareholding in The Economist Group and the Vedomosti joint venture in Russia.

However, it provided no details of with whom it is in discussions, and said there can be no certainty these talks will lead to a sale. "A further announcement will be made if and when appropriate," the company said. The statement follows a report from Reuters that Pearson was set to announce a sale of the Financial Times "imminently" to a "global digital news company".

Shares in Pearson are up 1.9% at 1,231 pence. Following the announcement, the stock reached a peak of 1,255.00p having traded at 1,210p prior to the Reuters report.

The FTSE 100 is up 0.2% at 6,680.45 points, the FTSE 250 is up 0.1% at 17,664.31, and the AIM All-Share is up 0.3% at 755.34. Similarly, European major indices also are enjoying modest gains, with the CAC 40 in Paris up 0.2% and the DAX 30 in Frankfurt up 0.1%.

US futures point to a higher open, with the DJIA and the S&P 500 both pointed up 0.2% and the Nasdaq 100 up 0.3%. Thursday is set to be one of the busiest days of the earnings season for the S&P 500, as investors await reports from Amazon.com, AT&T, Caterpillar, GM and McDonald's.

Both the S&P 500 and the Nasdaq Composite index are close to record highs, but CMC Markets analyst Jasper Lawler says, "the badly received results from Apple, coupled with the rout in commodities is hampering the possibility of a break out."

"That said, there is a slight recovery in the gold price today and a second set of conditions for a Greek bailout have been approved by the government in Athens," writes the analyst. "This backdrop alongside better corporate results on Thursday could be enough to spark a bigger turnaround."

The price of gold has recovered some ground since the sell-off earlier this week. The yellow metal is quoted at USD1,102.16 Thursday midday, having touched a low of USD1,073.40 on Monday.

FTSE 100-listed gold miners Fresnillo, up 1.8%, and Randgold Resources, up 1.7%, are benefiting from the rise in gold prices. In the FTSE 250, Acacia Mining, up 2.3%, and Lonmin, up 2.3%, are amongst the biggest mid-cap risers.

Unilever shares are up 2.2% after its results beat expectations. The consumer goods group posted underlying sales growth of 2.9% in its first-half, slightly ahead of the consensus for 2.7% growth, while second-quarter underlying sales growth, also of 2.9%, beat consensus estimates for 2.6% growth. The underlying figures strip out the impact of currency movements and any acquisitions or disposals.

Aberdeen Asset Management is the worst performer in the FTSE 100, trading down 7.9%, having hit its lowest level in over a year. The company said its assets under management dropped in the third quarter of its financial years amid outflows related to volatility in Asian and emerging markets.

Aberdeen said its assets under management fell to GBP307.3 billion at the end of June, down from GBP330.6 billion at the end of March. Aberdeen attributed the fall to market conditions and foreign exchange movements.

In the AIM All-Share, Victoria Oil & Gas is up 5.9%. The gas utility company said both gas production and sales more than doubled in the second quarter of 2015. Average gas production in the second quarter was 12.6 million standard cubic feet per day. That is more than double the 4.5 million cubic feet produced in the first quarter of 2015 and the 2.6 million produced a year earlier. Gas sales also leapt to 1.12 billion standard cubic feet from only 404.5 million cubic feet in the previous quarter and from 281.1 million cubic feet a year earlier.

Angle is down 3.2%. The company posted a widened pretax loss for its recently ended financial year, as it continued to progress its Parsortix cell separation system towards commercialisation. For the year to end-April the company posted a pretax loss of GBP3.9 million, widened from a pretax loss GBP2.2 million a year before, due to an increase in operating costs, as it increased investment in developing its key product Parsortix.

Outside corporate news, the pound took a hit against other major currencies following a disappointing set of UK retail sales figures for June.

Data from the Office for National Statistics showed that UK retail sales declined 0.2% from the prior month, reversing a 0.3% rise in May. This was the first drop in three months and went against expectations of a 0.4% gain. On a yearly basis, growth in retail sales including automotive fuel eased unexpectedly to 4.0% from 4.7% in May. Economists had expected 4.8% expansion.

The pound is down against the dollar at USD1.5596 from USD1.5652 before the data. Against the euro the pound slipped to a low of EUR1.4167 and is quoted Thursday midday at USD1.4185.

In Greece, the country's parliament overwhelmingly approved a second set of reforms needed to start talks on a third multi-billion euro bailout in the early hours of Thursday. The reforms, which are the final requirement before the country can start the bailout negotiations with its creditors, included lifting of liquidity of banks, deposit security and renewing of the judicial system. In the 300-seat parliament, 230 lawmakers voted in favour of the bill, with support for the ruling party coming from the pro-euro opposition parties.

In addition, the European Central Bank reportedly provided a vital new cash injection to Greece's liquidity-starved banks on Wednesday, the second such cash injection in just under a week.

Still ahead in the economic calendar, in the US, are initial and continuing jobless claims at 1330 BST and the US Conference Board leading indicator at 1500 BST, alongside eurozone consumer confidence.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more
11 Dec 2023 20:44

TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2023 11:50

IN BRIEF: Angle launches diagnostic kit at cancer symposium

Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium, following "extensive" development, optimisation and validation of the kit. Explains that the kit is read-to-use, and designed for the dentification, characterisation and enumeration of epithelial and mesenchymal cancer cells. This includes those undergoing epithelial-to-mesenchymal transition.

Read more
9 Nov 2023 14:29

Angle says build up of revenue slower than hoped; launches test

(Alliance News) - Angle PLC on Thursday said it expects revenue in 2023 to more than double from 2022 as it announced the launch of a new test aimed to support cancer therapy studies.

Read more
25 Oct 2023 17:28

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 Oct 2023 13:02

Angle hails study which shows Parsortix outperforming lab standard

(Alliance News) - Angle PLC on Tuesday touted the publication of a study by researchers at the University of Tubingen in Germany, which showed that its Parsortix system outperformed the current laboratory standard for disseminated tumour cell harvest.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.